Zai Lab Dirección
Dirección controles de criterios 3/4
El CEO de Zai Lab's es Samantha Du , nombrado en Jan 2014, tiene una permanencia de 10.25 años. compensación anual total es $20.21M, compuesta por 4.1% salario y 95.9% primas, incluidas acciones y opciones de la empresa. posee directamente un 1.03% de las acciones de la empresa, por valor de $15.96M. La antigüedad media del equipo directivo y de la junta directiva es de 3.5 años y 5.5 años, respectivamente.
Información clave
Samantha Du
Chief Executive Officer (CEO)
US$12.0m
Compensación total
| Porcentaje del salario del CEO | 7.2% |
| Permanencia del CEO | 10.3yrs |
| Participación del CEO | 1.1% |
| Permanencia media de la dirección | 3.6yrs |
| Promedio de permanencia en la Junta Directiva | 5.6yrs |
Actualizaciones recientes de la dirección
Recent updates
A Risky Bet: Zai Lab's Uncertain Future
Apr 16Lacklustre Performance Is Driving Zai Lab Limited's (NASDAQ:ZLAB) 29% Price Drop
Mar 29
We're Hopeful That Zai Lab (NASDAQ:ZLAB) Will Use Its Cash Wisely
Mar 24Why Investors Shouldn't Be Surprised By Zai Lab Limited's (NASDAQ:ZLAB) Low P/S
Jan 18Here's Why We're Not Too Worried About Zai Lab's (NASDAQ:ZLAB) Cash Burn Situation
Sep 22Zai Lab Limited's (NASDAQ:ZLAB) 25% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio
Jun 24We Think Zai Lab (NASDAQ:ZLAB) Can Afford To Drive Business Growth
Jun 02Is Zai Lab Limited (NASDAQ:ZLAB) Trading At A 44% Discount?
Feb 16Zai Lab (NASDAQ:ZLAB) Is In A Good Position To Deliver On Growth Plans
Jan 20We Think Zai Lab (NASDAQ:ZLAB) Can Afford To Drive Business Growth
Sep 19Zai Lab GAAP EPS of -$0.14 beats by $0.92, revenue of $48.17M beats by $1.04M
Aug 09China accepts Zai Lab's biologics license application for neuromuscular disorder drug
Jul 13Companies Like Zai Lab (NASDAQ:ZLAB) Are In A Position To Invest In Growth
Jun 03As Losses Narrow, Is Zai Lab Finally Finding Its Winning Formula?
May 18Zai Lab Revenue Triples As It Struggles To Break Cycle Of Mounting Losses
Mar 08Bearish: Analysts Just Cut Their Zai Lab Limited (NASDAQ:ZLAB) Revenue and EPS estimates
Mar 06Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Dec 31 2023 | US$12m | US$869k | -US$335m |
| Sep 30 2023 | n/a | n/a | -US$301m |
| Jun 30 2023 | n/a | n/a | -US$393m |
| Mar 31 2023 | n/a | n/a | -US$410m |
| Dec 31 2022 | US$20m | US$830k | -US$443m |
| Sep 30 2022 | n/a | n/a | -US$593m |
| Jun 30 2022 | n/a | n/a | -US$529m |
| Mar 31 2022 | n/a | n/a | -US$554m |
| Dec 31 2021 | US$15m | US$774k | -US$704m |
| Sep 30 2021 | n/a | n/a | -US$569m |
| Jun 30 2021 | n/a | n/a | -US$537m |
| Mar 31 2021 | n/a | n/a | -US$454m |
| Dec 31 2020 | US$9m | US$689k | -US$269m |
| Sep 30 2020 | n/a | n/a | -US$239m |
| Jun 30 2020 | n/a | n/a | -US$240m |
| Mar 31 2020 | n/a | n/a | -US$201m |
| Dec 31 2019 | US$9m | US$656k | -US$195m |
| Sep 30 2019 | n/a | n/a | -US$212m |
| Jun 30 2019 | n/a | n/a | -US$181m |
| Mar 31 2019 | n/a | n/a | -US$160m |
| Dec 31 2018 | US$6m | US$638k | -US$139m |
Compensación vs. Mercado: La compensación total de Samantha($USD20.21M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD5.61M).
Compensación vs. Ingresos: La compensación de Samantha ha sido consistente con los resultados de la empresa en el último año.
CEO
Samantha Du (57 yo)
10.3yrs
Permanencia
US$12,042,285
Compensación
Dr. Ying Du, Ph D., also known as Samantha, serves as Founding Managing Director at Quan Capital. She served as Venture Partner at Sequoia Capital China.Dr. Du serves as an adjunct professor at Fudan Univ...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Founder | 10.3yrs | US$12.04m | 1.13% $ 18.8m | |
| President & COO | 1.8yrs | US$5.55m | 0.029% $ 485.1k | |
| President and Head of Global Oncology Research & Development | 1.3yrs | US$4.87m | 0.024% $ 398.0k | |
| Chief Financial Officer | less than a year | US$2.01m | 0.0097% $ 162.6k | |
| President and Head of Global Development for Neuroscience | 7.3yrs | US$4.12m | 0.052% $ 875.9k | |
| Chief Scientific Officer | 1.5yrs | sin datos | sin datos | |
| Senior VP & Head of Investor Relations | less than a year | sin datos | sin datos | |
| Chief Legal Officer & Joint Corporate Secretary | 3.8yrs | US$5.63m | 0.027% $ 446.5k | |
| Chief Compliance Officer | 3.5yrs | sin datos | sin datos | |
| Executive VP & Head of Clinical Operations | 10.3yrs | sin datos | sin datos | |
| Chief Business Officer | 10.3yrs | sin datos | sin datos | |
| Chief Operating Officer of R&D | 9.3yrs | sin datos | sin datos |
3.6yrs
Permanencia media
57yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de ZLAB se considera experimentado (3.5 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Founder | 10.3yrs | US$12.04m | 1.13% $ 18.8m | |
| Independent Director | 4.3yrs | US$574.35k | 0.041% $ 685.1k | |
| Independent Director | 7.3yrs | US$576.15k | 0.37% $ 6.1m | |
| Lead Independent Director | 7.3yrs | US$608.44k | 0.069% $ 1.1m | |
| Member of Scientific Advisory Board | 8.3yrs | sin datos | sin datos | |
| Independent Director | 2.6yrs | US$570.77k | 0.027% $ 443.9k | |
| Independent Director | 5.6yrs | US$567.03k | 0.043% $ 714.1k | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of Scientific Advisory Board | 5.3yrs | sin datos | sin datos | |
| Independent Director | 2.5yrs | US$564.98k | 0.028% $ 470.4k | |
| Independent Director | 5.8yrs | US$557.48k | 0.048% $ 799.4k | |
| Member of Scientific Advisory Board | 4.4yrs | sin datos | sin datos |
5.6yrs
Permanencia media
66.5yo
Promedio de edad
Junta con experiencia: La junta directiva de ZLAB se considera experimentada (5.5 años de antigüedad promedio).